Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma

NCT04540107 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Recurrent World Health Organization (WHO) Grade II Glioma
Recurrent WHO Grade III Glioma
WHO Grade II Glioma
WHO Grade III Glioma

Interventions

DRUG: Hyperpolarized Carbon C 13 Pyruvate
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Magnetic Resonance Spectroscopic Imaging

Sponsor

Susan Chang

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]